• No.
• Generic Name
• Item
• Area
• Certification
• Note
• Structuer
• Purpose
• Inquiry

• 87
• Macitentan
• APIs & Intermediates
• Pulmonary Arterial Hypertension (PAH)

• USA

  -USDMF No. 031658

  Eu/ASMF 6 countries

  China

  -CDE Registration No.:Y20190000010

  WC to EU:ZJ240108
• 5 years stability
• 
• Inquiry

• 89
• Selexipag
• APIs & Intermediates
• Pulmonary arterial hypertension

• USA

  -ANDA No. 211026

  Tentative Approval

  China

  -CYHS1900599 Launched

  COPP:ZJ240108
• US DMF ready
• 
• Inquiry

• 94
• 4-Chlorophenethylamine
• 
• Inquiry

• 120
• Macitentan tablet 10mg
• Formulation
• 
• Inquiry

• 121
• Selexipag tablet
• Formulation
• Inquiry

• 122
• Vortioxetine tablet 5mg
• Formulation
• 
• Inquiry

• 123
• Vortioxetine tablet 10mg
• Formulation
• 
• Inquiry

• 124
• Vortioxetine tablet 20mg
• Formulation
• 
• Inquiry

• 133
• N-Propylsulfamide sodium salt
• other
• Macitentan
• Inquiry

• 134
• Macitentan;N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
• other
• 
• Inquiry

• 135
• Rapamycin;Sirolimus;23,27-Epoxy-3h-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
• other
• 
• Inquiry

• 136
• 4-(4-Nitrophenyl)morpholin-3-one
• other
• 
• Rivaroxaban
• Inquiry